Wyden Statement on the Taxpayer First Act
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today released the following statement on the Taxpayer First Act: “Again and again in my service in the Senate I have battled the tax-preparation software industry to simplify filing taxes for the typical American. In fact, the industry spent millions and millions of dollars to fight my […]
Wyden Statement at Finance Committee Hearing on Drug Prices and Pharmacy Benefit Managers
This morning the Finance Committee continues our work on pharmaceutical price gouging, which does enormous harm to consumers and taxpayers. There’s a lot of work to do in the days ahead, but this committee has already put points on the board. Just last week, Congress passed our bipartisan legislation that stopped a blatant scheme big […]
Wyden: Big Pharma Refuses to Commit to Lower Prices, Action by Congress Needed
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today decried drug makers’ refusal to commit to lowering drug prices if middlemen rebate practices were changed. “In case there was any doubt, Big Pharma is not about to start self-policing their pricing practices,” Wyden said. “In order to prevent a cash grab that gives drug […]
Wyden Statement on OGE’s Refusal to Certify Mnuchin’s Financial Disclosure Report
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today released the following statement on the status of Steven Mnuchin’s financial disclosure report: “I am concerned by the Office of Government Ethics’ refusal to certify Secretary Steven Mnuchin’s 2018 financial disclosure report. Before being confirmed by the Senate, he signed an ethics agreement that said he […]
Wyden Statement on Reports of Ways and Means Drug Pricing Markup
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement after news reports indicated the House Ways & Means Committee will be marking up drug pricing legislation including Wyden-initiated bills that address price gouging and secrecy in the drug pricing system: “I am pleased that the House is advancing my bills to bring […]
Wyden Statement on Reported China Trade Summit
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today released the following statement on reports that the administration would soon announce a summit with China to complete a trade agreement: “We’ve had nearly two decades of broken promises from China. Any deal that fails to address the core trade cheating by China – theft of […]
Wyden Statement on House Ways & Means Committee’s Request for Trump Tax Returns
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today released the following statement in response to House Ways & Means Chairman Richard Neal, D-Mass., requesting President Donald Trump’s tax returns under Section 6103 of the tax code: “Secretary Mnuchin should have no involvement in responding to Chairman Neal’s request for President Trump’s tax returns. Tax […]
Wyden, Grassley Praise Congressional Passage of Right Rebate Act
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and Senate Finance Committee Chairman Chuck Grassley, R-Iowa, today celebrated congressional passage of their bill to prevent drug makers from manipulating Medicaid to gouge taxpayers and increase profits by misclassifying their drugs. The legislation was included in a broader package of Medicaid policies, called […]
Wyden to Unveil Plan to Ensure Wealthy Pay Their Fair Share
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today announced that he is developing a mark-to-market approach to eliminate a host of loopholes and ensure the wealthy pay their fair share in taxes. He will soon release a detailed white paper outlining how the gains on assets owned by millionaires and billionaires would […]
Republicans Refuse to Support Pre-Existing Condition Protections, Double Down on Tax Cuts for Corporations and Billionaires
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today called on Senate Republicans to pass a budget that guarantees protections for pre-existing conditions and blocks additional tax cuts for corporations and billionaires. In a Senate Budget Committee markup, Wyden offered two amendments to adopt these commonsense policies, but Republicans voted them down […]